Managing Keratoconus: A Patient’s Journey

For one family in Nebraska, a routine back-to-school eye exam turned into an interstate journey to understand what was wrong with their son’s vision. When an optometrist located in the Yankton Walmart noticed an irregularity in Baylen’s left cornea during his eye exam, he referred the family to Vance Thompson Vision in Sioux Falls. There, … Continued

Dr. Audrey Talley Rostov – Managing the (Un)usual Keratoconus Patients

“With proper ‘verbal anesthesia’ and appropriate precautions for unusual cases, a wide range of patients diagnosed with progressive keratoconus or post-refractive ectasia can be treated very successfully.” Most patients treated for progressive keratoconus are older teens or adults in their 20s and 30s, however, there are some that don’t fit the typical patient population. They … Continued

Using Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution), Photrexa® (riboflavin 5’-phosphate ophthalmic solution), and the KXL® System, the iLink™ corneal cross-linking procedure from Glaukos is the only FDA-approved therapeutic treatment for patients with progressive keratoconus and corneal ectasia following refractive surgery.*1

[Photrexa IFU/p1/col1/para3/lines1-4]


Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution) and Photrexa® (riboflavin 5’-phosphate ophthalmic solution) are indicated for use with the KXL System in corneal collagen cross-linking for the treatment of progressive keratoconus and corneal ectasia following refractive surgery.

Important Safety Information

Corneal collagen cross-linking should not be performed on pregnant women.

Ulcerative keratitis can occur. Patients should be monitored for resolution of epethelial defects. The most common ocular adverse reaction was corneal opacity (haze). Other ocular side effects include punctate keratitis, corneal striae, dry eye, corneal epithelium defect, eye pain, light sensitivity, reduced visual acuity, and blurred vision.

These are not all the side effects of the corneal collagen cross-linking treatment. For more information, go to obtain the FDA-approved product labeling.

You are encouraged to report all side effects to the FDA. Visit, or call 1-800-FDA-1088.

*Photrexa® Viscous and Photrexa® are manufactured for Avedro. The KXL® System is manufactured by Avedro. Avedro is a wholly owned subsidiary of Glaukos Corporation.


1. Photrexa [package insert]. Waltham, MA: Glaukos, Inc. 2016